FDA.reportPublic FDA data

insulin aspart-szjj 100 UNT/ML Injectable Solution [Merilog]

RxCUI
2705739
RxNorm name
insulin aspart-szjj 100 UNT/ML Injectable Solution [Merilog]
Display name
insulin aspart-szjj 100 UNT/ML Injectable Solution [Merilog]
Full name
insulin aspart-szjj 100 UNT/ML Injectable Solution [Merilog]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:27

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761325Meriloginsulin aspart-szjj351(k) BiosimilarRx2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
MERILOGINSULIN ASPART-SZJJSanofi-Aventis U.S. LLCeee07a52-1102-4d48-9782-26061db175ad2025-10-07Warnings, Adverse reactionsExact identifier
rxcui: 2705739

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
eee07a52-1102-4d48-9782-26061db175adinsulin aspart-szjj 100 UNT/ML Injectable Solution [Merilog]SBD8These highlights do not include all the information needed to use MERILOG safely and effectively. See full prescribing information for MERILOG™. MERILOG (insulin aspart-szjj) injection, for subcutaneous use. Initial U.S. Approval: 2025 MERILOG™ (insulin aspart-szjj) is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and that there are no clinically meaningful differe20251007
eee07a52-1102-4d48-9782-26061db175adMerilog 100 UNT/ML Injectable SolutionPSN8These highlights do not include all the information needed to use MERILOG safely and effectively. See full prescribing information for MERILOG™. MERILOG (insulin aspart-szjj) injection, for subcutaneous use. Initial U.S. Approval: 2025 MERILOG™ (insulin aspart-szjj) is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and that there are no clinically meaningful differe20251007
eee07a52-1102-4d48-9782-26061db175adMerilog 100 UNT/ML Injectable SolutionSY8These highlights do not include all the information needed to use MERILOG safely and effectively. See full prescribing information for MERILOG™. MERILOG (insulin aspart-szjj) injection, for subcutaneous use. Initial U.S. Approval: 2025 MERILOG™ (insulin aspart-szjj) is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and that there are no clinically meaningful differe20251007